Clinical Trial Update: Minimum Dose Computed Tomography of the Thorax for Follow-up in Patients With Resected Lung Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating minimum dose computed tomography for follow-up in patients with resected non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: University Health Network, Toronto | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED